Latest News about MRSN
Recent news which mentions MRSN
From Benzinga
Cancer Drug Trials Put On Hold After Patients Died
June 17, 2023
From Benzinga
From Benzinga
From Benzinga
Crude Oil Rises Sharply; Jabil Posts Upbeat Q3 Results
June 15, 2023
From Benzinga
Mersana's UpRi Shows Potential in Ovarian Cancer; Analyst Initiates Coverage with Buy Rating
June 15, 2023
From Benzinga
Mersana Therapeutics’s stock craters after FDA halts trials of ovarian cancer treatment after patient deaths
June 15, 2023
From MarketWatch
From Benzinga
Why John Wiley & Sons Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
June 15, 2023
From Benzinga
Dow Surges Over 300 Points; Kroger Profit Beats Views
June 15, 2023
From Benzinga
From Benzinga
US Stocks Open Higher; Retail Sales Rise In May
June 15, 2023
From Benzinga
From Motley Fool
From Benzinga
7 Stocks to Buy for 200% Returns This Year
June 13, 2023
From InvestorPlace
From Benzinga
From Benzinga
From Benzinga
With Upcoming Ovarian Cancer Data, Analyst Sees 100% Upside For Mersana Therapeutics
January 20, 2023
From Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
January 03, 2023
From Benzinga
Mersana Inks Cancer Therapy Development Deal With Merck Germany
December 23, 2022
From Benzinga
Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day Session
December 19, 2022
From Benzinga
Mersana Therapeutics's Return On Capital Employed Insights
November 30, 2022
Tickers
MRSN
From Benzinga
Why Huadi International Group Shares Dipped Around 91%; Here Are 79 Biggest Movers From Yesterday
November 08, 2022
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.